The structural anatomy of the basal ganglia has been reasonably well known for many years and in the past has led to valuable insights into the brain basis of a number of movement disorders. However, over the past 15 years or so there has been a massive increase in our understanding of the functional anatomy of the basal ganglia. This knowledge is increasingly revealing the important role that this complex brain region plays in patterns of brain activity that also involve many of the brain regions previously implicated in psychopathology, such as the limbic system and the prefrontal cortex. Recent findings Many aspects of psychiatric disturbance have been linked to disturbances in the basal ganglia, their connections with other brain regions or these distant sites themselves. Recent findings have in particular shed new light on aspects of schizophrenia, obsessive compulsive disorder, drug addiction and the behavioural concomitants of movement disorders. Summary Taken together, the observations reported in this review demonstrate that increased understanding of the role played by the basal ganglia and their connections shed light not only on the basic pathophysiology of several psychiatric states but also on some of the effects of established therapeutic interventions in these conditions, as well as suggesting potentially new avenues for future therapeutic developments.
Introduction
The basal ganglia are large sub-cortical nuclear masses. The commonly recognized components include the caudate nucleus, the putamen and the globus pallidus. This relatively limited definition reflects what used to be considered the almost exclusively motor functions of the basal ganglia. The greatest change in our understanding of the basal ganglia in recent years has been the recognition that these structures play important roles in cognitive, behavioural and emotional functions as well as just in motor activity [1,2
. ,3 . . ,4 . ]. Supporting this functional re-evaluation has been the recognition that a wider range of structures should also be included within the definition of the basal ganglia.
The ventral striatum describes those parts of the basal ganglia closest to limbic structures. The term includes the nucleus accumbens and the deepest parts of the olfactory tubercle. A number of authorities also include the amygdala within a consideration of the basal ganglia as it occupies an important position between the basal ganglia and the limbic system and may play a role in integrating activity between these structure [5] .
Psychiatric disorders associated with basal ganglia disturbances
Studies of the biology of primary psychiatric disorders now consider not just cortical areas but also subcortical regions. The basal ganglia and their connections to cortex are being increasingly recognized as being implicated in the generation of psychiatric symptoms and the distinctions between 'neurological' movement disorders and 'functional' psychiatric disorders is in several circumstances becoming increasingly difficult to maintain.
Schizophrenia
Limbic and prefrontal cortico-striato-pallidal circuits that include the nucleus accumbens mediate several cognitive, emotional and psychomotor processes that are disturbed in schizophrenia. It has been suggested that disturbances in the functioning of these circuits may have a number of effects, such as disturbances in motivational behaviour, overloading of input to the cerebral cortex and a breakdown in the integrative capacity of the brain that may be relevant to the generation of schizophrenic symptoms [6] . Lauer et al. [7] observed that in the brains of patients who had been schizophrenic, hemisphere-adjusted nucleus accumbens volumes, both on the left and the right, were greater than they were in normal controls. Although there was no information regarding medication use in their patients, overall the authors concluded that their findings are compatible with a decreased rate of naturally occurring cell death arising as a result of disturbances in prenatal cortical neurodevelopment, supporting this model of a neurodevelopmental cause of schizophrenia.
There have also been advances in our understanding of the effect of antipsychotic medications on the basal ganglia. The relationship between schizophrenia, antipsychotics and brain volumes has been much studied and it was previously noted that chronic treatment with typical antipsychotics was associated with enlargement of basal ganglia structures which decreased when patients were switched to atypical agents [8] . In a recent useful addition to this field, Lang et al. [9] examined 30 first-episode schizophrenic patients who went on to receive a year of risperidone treatment, 12 chronically treated schizophrenic patients and 23 healthy controls. Using structural magnetic resonance imaging, a baseline volumetric analysis of the basal ganglia found that they were significantly larger in the chronically treated group than in either the first episode or the healthy control groups (who did not differ). Furthermore, after a year of risperidone, the first episode group still did not differ from the healthy control group. Hence this study, within the limits of a 1-year follow-up period, supports the proposition that unlike the typical neuroleptics, the atypical drugs do not lead to enlargement of the basal ganglia. In this study the nucleus accumbens volume was included with that of the caudate. The significance of the enlarged basal ganglia in the chronically treated patients was, however, not clear. There was no significant correlation within this group between the basal ganglia volumes and clinical data including duration of treatment, or total lifetime neuroleptic dose. However, a range of studies has demonstrated that typical neuroleptics increase striatal neuronal activation, which may contribute to the observed enlargement.
Interestingly, the authors found that 10 of their nevertreated, first episode patients had pre-existing movement disorders. Similar observations have been reported previously over the years but the significance of these, beyond suggesting that the pathophysiology of schizophrenia itself perturbs striatal functioning, remains to be clarified.
Addiction
The mesolimbic dopaminergic system and the connections of the orbitofrontal cortex with the ventral tegmental area, the nucleus accumbens and the thalamus are important for drug reinforcement and addiction [10] ; and changes within mesocortical structures and pathways may be particularly important in the compulsive aspect of drug taking behaviour. In early cocaine withdrawal, metabolism is increased in orbitofrontal cortex and striatum and the magnitude of this increase is significantly correlated with the intensity of craving [11] . Dopaminergic neurotransmission in the mesolimbic dopaminergic system is terminated by its re-uptake through a dopamine transporter (DAT), which is known to be a target for cocaine, which blocks dopamine reuptake. It has been suggested that changes in dopamine transport may be one of the specific mechanisms by which cocaine use progresses to compulsive dependence. In studies in primates it was demonstrated that, whilst initial cocaine exposure leads to decreased DAT-binding sites, longer exposures, of between 3 and 12 months, lead to increased density of DAT-binding sites within the limbic striatum [12] . In post-mortem examinations of dopamine uptake in human chronic cocaine abusers it was demonstrated that there are increased DAT levels and increased dopamine uptake [13 . ]. The authors of this study go on to suggest that these changes with chronicity would lead to decreased amounts of dopamine available in the synaptic cleft. They go on to suggest that in these circumstances, in chronic cocaine users, the need to maintain dopamine homeostasis, in dopamine systems that play a role in reward mechanisms, may be one of the factors that drive the compulsive use of cocaine.
It has also been demonstrated that through conditioning, non-drug stimuli associated with drug exposure can become motivational factors maintaining drug addiction, as is recognized clinically. Martin-Soelch et al. [14] recently described some of the functional brain changes underlying this. They demonstrated, using H 2 15 O positron emission tomography, that in opiate addicts, monetary and non-monetary rewards differ in their effects on brain regions linked to mesocortico-limbic circuits, whilst in controls both types of rewards activated similar areas. The authors suggest that their findings indicate that in addicts non-monetary reward has insufficient motivational value to activate reward-related regions. It may be that this narrowing of the stimuli which activate reward pathways contributes to the narrowing of behaviour to activities related to their drug-taking, which may be observed in addicts.
Obsessive compulsive disorder
There has in recent years been much research into the biological basis of obsessive compulsive disorder (OCD) and a large number of studies have reported a range of abnormalities in the functioning of striatum and sites within the prefrontal (largely orbital prefrontal) cortex. However, in many patients with OCD there are also concomitant symptoms of depression. Indeed clinically, the development of significant symptoms of OCD within the context of a pre-existing major depressive disorder is well recognized. However, the relative contribution of the biology of depression to the cognitive disturbances that have been observed in people with OCD is not clear. A study by Basso et al. [15] explicitly explored this area, drawing findings from a retrospective survey of 20 adults with OCD, in whom a battery of clinical and psychological data had been collected as part of a diagnostic evaluation. In particular, the study sought to explore the proposition that the executive function disturbances that have been reported in people with OCD are associated with depressive, as opposed to obsessive compulsive symptomatology. The authors examined data from patients with a primary diagnosis of OCD and a range of depressive symptoms. Depressive severity was measured with the depression scale of the Minnesota Multiphasic Personality Inventory. As well as several executive function tests (including the Wisconsin Card Sorting Test) the subjects were also assessed on tests for manual dexterity and astereognosis. Whilst the patients with OCD performed more poorly than the controls on all these tasks, the performance decrement on the executive function tasks did not remain significant once depression score was added into the regression analysis. However, performance on the tests of motor function and tactile sensation remained worse than that seen in the controls. These data support previous observations that those studies in patients with OCD, in which patients with concomitant depression are not excluded, tend to show disturbances of executive function that are not seen in studies which do exclude such patients. The findings of Basso et al. [15] are limited by relatively small numbers, the retrospective analysis of data and the choice of assessments. Nevertheless, the study supports the notion that disturbances of executive function seen in people with OCD are more related to the presence of depression than to core obsessive compulsive pathophysiology, whilst this pathophysiology, whatever it is, though it predominantly leads to recognized obsessive compulsive behaviours, also has some effect on other aspects of complex motor functioning.
Obsessive compulsive disorder associated with symptoms of movement disorder Related to this latter point, several recently published studies have added to the literature describing the increased prevalence of OCD that has been noted in patients with movement disorders. In a very large study of the rate of functional decline in patients with Huntington's disease [16] the authors noted that of the 960 patients studied, 22% had obsessive and compulsive symptoms at their first clinic visit. The nature of this association was subsequently looked at in more detail, in a much smaller sample, by Anderson et al. [17] who examined obsessive compulsive symptoms in a group of 27 patients with Huntington's disease. They found that 14 of their subjects had at least one obsession (most frequently an 'aggressive' obsession), whilst seven subjects had at least one current compulsive symptom (most commonly checking). Comparing those with obsessive compulsive symptoms with those without demonstrated that the presence of obsessions or compulsions was associated with a greater degree of cognitive impairment on a range of neuropsychological tests including the Stroop task, verbal fluency and digitsymbol tasks. The authors considered that disturbed performance on these cognitive tasks was indicative of corticostriatal dysfunction and suggested that their results indicated that it was those patients with more pronounced caudate pathology who were more likely to develop obsessive compulsive symptoms. Whilst these results are helpful in understanding the clinical problems that may develop in patients with Huntington's disease, and in emphasizing the role of the caudate nucleus in the generation of behavioural symptoms, it would, as noted above, have been interesting to know how much of the cognitive disturbance observed could have been explained by the presence of comorbid depressive symptoms.
Obsessive compulsive symptoms have also been noted to occur with increased frequency in other disorders characterized by abnormalities of movement. Interestingly, in both idiopathic dystonia and Gilles de la Tourette syndrome (GTS) -two conditions with unusual movement disorders and no clearly established pathophysiological basis -increased rates of OCD have been observed. In one survey of 76 patients with idiopathic focal dystonia, nearly 20% were found to satisfy the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for a diagnosis of OCD [18 . ].
Of particular significance, it was also found that there was an increased morbidity risk for OCD in the first degree relatives of those with dystonia and OCD, of 13.8%. This is considerably above the risk in first degree relatives of those with dystonia but no OCD or in the general population. These findings suggest that a proportion of patients with dystonia have a genetic liability to OCD and that within this subgroup the two conditions may share some pathophysiological mechanisms related to basal ganglia 'instability' which in the families of the dystonic probands is expressed as an increased risk of OCD.
In the above study by Cavallaro et al. [18 . ] only one of their patients also reported tics and the authors suggest that if this low comorbidity was not an artifact of their study methodology then dystonia with OCD may not share any pathological features with GTS. In this context it is interesting to consider the report by Kwak and Jankovic [19] of two boys who developed dystonia, motor tics and obsessive compulsive symptoms after right hemisphere basal ganglia strokes. As the authors note, in the absence of any possibly aetiological family history of GTS in the two boys, these cases suggest a shared mechanism by which tics and dystonia may both develop.
Thus evidence continues to accumulate of a causative role for the basal ganglia in the spectrum of conditions that variously include dystonia, tics and OCD. However, the fact that these three conditions do not always coexist within the same individual indicates that other as yet unknown factors, such as the precise physical extent of damage within the striatum or extended cortico-striatopallido-thalamo-cortical circuits or additional genetically determined pathophysiological mechanisms, remain to be determined.
Movement disorders
Recent developments regarding some of the behavioural consequences of disturbed basal ganglia function occurring in primarily psychiatric contexts have now been discussed. However, the neurological diseases that were previously thought to be the only significant manifestations of basal ganglia pathology also, and not surprisingly in the light of the various observations made above, have a range of associated behavioural disturbances.
Parkinson's disease
Advances in our knowledge of the neuropsychiatry of the basal ganglia are also leading to a better understanding of some of the behavioural aspects of Parkinson's disease. The motor slowing or bradykinesia of Parkinson's disease is well recognized as one of the cardinal symptoms of the condition. However, it has also been acknowledged for some time that slowness of cognitive processes appears to also be characteristic of the disorder, although it can be difficult to clearly distinguish bradykinesia from bradyphrenia experimentally and clinically. Indeed, cognitive and motor processing may interact. Sawamoto et al. [20 . ] developed an experimental paradigm involving the updating of a mental representation of a visual stimulus. The authors found, in their sample of patients with relatively mild Parkinson's disease, that magnitudes of cognitive and motor slowing were correlated in their study sample. They also noted that cognitive slowing became more apparent in circumstances of increasing cognitive demands. Having previously also measured patterns of regional cerebral blood flow (using H 2 15 O positron emission tomography), during performance of the same tasks, the authors concluded that the cognitive slowing seen in Parkinson's disease results from disturbances in the striatum, the medial premotor cortex, or both.
Conclusion
In conclusion, it may be seen that studies of the cerebral basis of clinical psychopathological states on one hand and investigations into the biology of the basal ganglia on the other are both progressing steadily. They are increasingly providing complementary findings that will support the aim of being able to pursue the biological causes of a range of psychiatric symptoms down to disturbances of specific brain regions, neurotransmitter systems and functional anatomic circuits. 
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